| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Synthesis, antimycobacterial activity, and computational insight of novel 1,4-benzoxazin-2-one derivatives as promising candidates against multidrug-resistant mycobacterium tuberculosis
Authors:ID Mamolo, Maria Grazia (Author)
ID Carosati, Emanuele (Author)
ID Pasin, Diletta (Author)
ID De Logu, Alessandro (Author)
ID Cabiddu, Gianluigi (Author)
ID Jukič, Marko (Author)
ID Zampieri, Daniele (Author)
Files:.pdf ChemMedChem_-_2025_-_Mamolo_-_Synthesis__Antimycobacterial_Activity__and_Computational_Insight_of_Novel_1.pdf (1,77 MB)
MD5: 692D0921DC84033223AB466968980221
 
Language:English
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FKKT - Faculty of Chemistry and Chemical Engineering
Abstract:In the search for new antitubercular agents, a series of 1,4-benzoxazinone-based compounds is designed, synthesized, and evaluated. These molecules show potent antimycobacterial activity, with a minimum inhibitory concentration between 2 and 8 μg mL−1. This interesting profile includes activity against several drug-resistant strains and minimal cytotoxicity against mammalian Vero cells. Structural similarities with analogs from the literature are reinforced by molecular docking and molecular dynamics simulations, suggesting that inhibition of the menaquinone-B enzyme as a potential mechanism of action. In addition, the active compounds exhibit favorable predicted Absorption, Distribuition, Metabolism, and Excretion (ADME) properties, indicating their potential for oral administration in humans.
Keywords:antimycobacterial, benzoxazinones, cytotoxicities, dockings, menaquinone-B, minimum inhibitory concentrations
Publication status:Published
Publication version:Version of Record
Submitted for review:28.01.2025
Article acceptance date:12.05.2025
Publication date:14.05.2025
Publisher:Wiley
Year of publishing:2025
Number of pages:11 str.
PID:20.500.12556/DKUM-93640 New window
UDC:579.6
ISSN on article:1860-7187
COBISS.SI-ID:241809155 New window
DOI:10.1002/cmdc.202500073 New window
Copyright:© 2025 The Authors
Publication date in DKUM:09.07.2025
Views:112
Downloads:9
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:ChemMedChem
Shortened title:ChemMedChem
Publisher:Wiley-VCH-Verl..
ISSN:1860-7187
COBISS.SI-ID:519053337 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-50043-2023
Name:Mutacijska platforma koronavirusnih terapevtskih tarč za študij vpliva mutacij na učinkovitost in izbiro zdravil ter načrtovanje novih pan-koronavirusnih zaviralcev

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:antimikrobno, citotoksini, inhibitorji


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica